We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

In Utero Stem Cell Transplants Could Revolutionize Thalassemia Treatment

News   May 29, 2018 | Original story from UCSF

 
In Utero Stem Cell Transplants Could Revolutionize Thalassemia Treatment

Newborn Elianna is held by her mother, Nichelle Obar, and father, Chris Constantino. Elianna was born at UCSF Benioff Children’s Hospital San Francisco after receiving an in utero stem cell transplant to treat a lethal form of thalassemia. Credit: Noah Berger

 
 
 

RELATED ARTICLES

From Fibroblast to Antigen-presenting Dendritic Cell: a Pioneering Approach

News

Direct programming of mouse and human skin cells into antigen-presenting dendritic cells opens up the possibility of developing novel dendritic cell-based immunotherapies against cancer.

READ MORE

First Bioprinted Organ in Space

News

Russian astronauts onboard a spacecraft have reportedly bioprinted a mouse thyroid. This is definitely a world-first in outer space bioprinting.

READ MORE

T Cell Activation's New Player

News

A key protein responsible for the relocation of the MTOC in activated T cells is a molecule known as CLIP-170, a microtubule-binding protein.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE